The emerging treatment of this peptide represents a major breakthrough in the care of the condition. Distinct from existing drugs, tirzepatide affects dual pathways – GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) – leading to greater blood sugar control … Read More